Menon Sandeep bought BCRX
April 6, 2026 · Form 4 insider transaction
Menon Sandeep bought 205,150 shares of BioCryst Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
205,150
Price
$0.00
Total value
N/A
InsiderMenon Sandeep
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 6, 2026
Filing dateApril 7, 2026
Shares owned after205,150
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Inducement grant of restricted stock units pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan, as amended and restated (the "Stock Incentive Plan"), which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.